Scientists at deCODE genetics, a subsidiary of Amgen,�reveal today in Nature Genetics associations between rare loss-of-function variants in two genes and bipolar disorder. Significant progress has ...

With just 48 hours to experiment before it would become unusable, a group of nearly 20 researchers focused intently on creating a brand-new molecule. Using a chemical glove box, a polycarbonate ...

Read the paper: A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosome The authors’ discovery of lariocidin (LAR) is important because ample data supports this molecule as ...

Neuroblastomas are the most common cancer in infants, with about 700–800 diagnoses per year in the US, according to the American Cancer Society. Some of the most high-risk cases are driven by elevated ...

As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...